From: Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
Control | OVX | LiCl | Ly294002 | LiCl + ly294002 | |
---|---|---|---|---|---|
BMD (mg HA/ccm) | 651.93 ± 15.5 | 503.46 ± 14.3** | 569.76 ± 13.6**## | 577.07 ± 15.8**## | 605.72 ± 14.1**##□□△△ |
BV/TV (%) | 0.2734 ± 0.03 | 0.0384 ± 0.01** | 0.0863 ± 0.01**## | 0.08 ± 0.01**## | 0.1352 ± 0.02**##□□△△ |
SMI | 1.1439 ± 0.1762 | 2.7716 ± 0.2553** | 2.3604 ± 0.231**## | 2.5083 ± 0.2275**## | 2.0728 ± 0.1931**##□△△ |
COD (mm−3) | 170.4669 ± 13.0462 | 14.1078 ± 1.437** | 57.0813 ± 4.1097**## | 46.9949 ± 3.7431**## | 81.2214 ± 5.9857**##□□△△ |
BS/BV (mm−1) | 35.685 ± 1.04 | 50.2093 ± 3.98** | 48.7623 ± 2.6** | 48.4133 ± 2.81** | 46.5063 ± 2.22**## |
Tb.N (mm−1) | 4.7613 ± 0.41 | 0.9894 ± 0.08** | 2.0506 ± 0.17**## | 1.9949 ± 0.15**## | 3.5802 ± 0.28**##□□△△ |
Tb.Sp (mm) | 0.1952 ± 0.014 | 1.0327 ± 0.072** | 0.4933 ± 0.032**## | 0.5059 ± 0.041**## | 0.2699 ± 0.019**##□□△△ |
Tb.Th (mm) | 0.0712 ± 0.006 | 0.0569 ± 0.004** | 0.0556 ± 0.004** | 0.0581 ± 0.004** | 0.0585 ± 0.004** |